Steven M. Fruchtman - Mar 13, 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
PRESIDENT, CHIEF EXECUTIVE OFF, Director
Signature
/s/ Mark Guerin, Attorney-in-Fact
Stock symbol
ONTX
Transactions as of
Mar 13, 2023
Transactions value $
$0
Form type
4
Date filed
3/14/2023, 06:48 PM
Previous filing
Feb 8, 2023
Next filing
Aug 4, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Stock Option (right to purchase) Award $0 +207K $0.00 207K Mar 13, 2023 Common Stock 207K $0.73 Direct F1
transaction ONTX Restricted Stock Units Award $0 +69.3K $0.00 69.3K Mar 13, 2023 Common Stock 69.3K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
F2 Each restricted stock unit is convertible into one share of common stock.
F3 These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary